We are live on ! Find out more
NVPX

Norwest Venture Partners XIV Portfolio holdings

AUM $60.4M
1-Year Est. Return 9.56%
This Fund
S&P 500
This Quarter Est. Return
-24.09%
1 Year Est. Return
+9.56%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.6M
AUM Growth
-$8.01M
Cap. Flow
+$16.9M
Cap. Flow %
19.54%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
+$36.7M

Top Sells

Rank Stock Value
1
OPEN icon
Opendoor
OPEN
+$19.8M

Sector Composition

Rank Sector Weight
1 Real Estate 68.55%
2 Healthcare 31.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPEN icon
1
Opendoor
OPEN
$3.71B
$59.4M 68.55%
3,460,174
-1,153,391
-25% -$19.8M
IMPL
2
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$27.2M 31.45%
+3,077,198
New +$36.7M

Similar funds

MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
SCC
Six Columns Capital Dallas, Texas $68M AUM 111.71% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
CIM
Coastal Investment Management Los Angeles, California $71.8M AUM 80.55% 1-Year Est. Return
C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return

Norwest Venture Partners XIV's Q2 2021 Portfolio in Review

As of Q2 2021, Norwest Venture Partners XIV held 2 positions worth $86.6M, down 8.5% from $94.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Norwest Venture Partners XIV deployed $16.9M of net new capital in Q2 2021, opening 1 new position. Its largest new stake was Impel Pharmaceuticals Inc. Common Stock: 3,077,198 shares worth $27.2M.

By sector, the portfolio is most concentrated in Real Estate at 69% of assets, down from 100% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Opendoor, an estimated $19.8M trimmed.

  • Norwest Venture Partners XIV's largest Q2 2021 buy was Impel Pharmaceuticals Inc. Common Stock: 3,077,198 shares worth $27.2M.
  • Norwest Venture Partners XIV's biggest Q2 2021 reduction was Opendoor, cutting an estimated $19.8M.
  • Norwest Venture Partners XIV's ten largest holdings make up 100% of its $86.6M portfolio in Q2 2021.
  • Norwest Venture Partners XIV opened 1 new position and closed 0 in Q2 2021.
  • Norwest Venture Partners XIV's portfolio value fell 8.5% quarter-over-quarter to $86.6M.

Based on Norwest Venture Partners XIV's 13F filing for Q2 2021, filed 10 Aug 2021.